SuperworthFossil market cap FOSL
Share price times shares outstanding: what the whole company sells for, since 2010.
- Today, Oct 23, 2026
- $390.3M
- Highest close in our data
- $8.5B
- Apr 2012
Fossil is worth $390.3M at the close on Oct 23, 2026, at $6.60 a share.
That is up 216% over the last year and down 37% over five years.
Its highest close in our data was $8.5B in Apr 2012.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $390.3M | $186.3M | $422.8M | +86% |
| 2025 | $210.4M | $48.2M | $213.1M | +109% |
| 2024 | $100.5M | $41.5M | $105.9M | +31% |
| 2023 | $76.6M | $58.8M | $301.7M | −66% |
| 2022 | $223.4M | $177.2M | $747.8M | −58% |
| 2021 | $536.6M | $504.2M | $888.4M | +20% |
| 2020 | $446.3M | $145.7M | $684.1M | +14% |
| 2019 | $391M | $362.7M | $890.2M | −51% |
| 2018 | $802.7M | $363M | $1.5B | +113% |
| 2017 | $377.1M | $320.3M | $1.2B | −70% |
| 2016 | $1.2B | $1.2B | $2.5B | −29% |
| 2015 | $1.8B | $1.6B | $5.6B | −69% |
| 2014 | $5.6B | $5.1B | $6.7B | −15% |
| 2013 | $6.6B | $5.5B | $7.3B | +24% |
| 2012 | $5.4B | $4.2B | $8.5B | +8% |
| 2011 | $5B | $4.5B | $8.4B | +8% |
| 2010 | $4.6B | $2.9B | $4.8B | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Fossil's size, closest first, today.
| Company | Market cap |
|---|---|
| FOSLFossil | $390.3M |
| EMBCEmbecta | $380.2M |
| TCMDTactile Systems Technology | $535.5M |
| INFUInfuSystem | $277.6M |
| MDXGMimedx | $569.9M |
| UTMDUtah Medical Products | $236.3M |
| MOVMovado | $701.9M |
| PDEXPro DEX | $199.3M |
| IRMDIradimed | $1.1B |
| STAAStaar Surgical | $1.1B |
| BVSBioventus | $1.3B |
| Peer median | $552.7M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Fossil
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.